BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+0.51%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$9.85B
AUM Growth
+$9.85B
(-3.8%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-1.35%
Top 10 Holdings %
Top 10 Hldgs %
29.91%
Holding
226
New
13
Increased
56
Reduced
57
Closed
7
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$52.6M |
| 2 |
Revolution Medicines
RVMD
|
$44.1M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$37.4M |
| 4 |
Fate Therapeutics
FATE
|
$37M |
| 5 |
AMED
Amedisys
AMED
|
$36.1M |
Top Sells
| 1 |
Moderna
MRNA
|
$314M |
| 2 |
Halozyme
HALO
|
$53M |
| 3 |
Charles River Laboratories
CRL
|
$47.4M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$38M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$30.8M |
Sector Composition
| 1 | Healthcare | 96.84% |
| 2 | Industrials | 0.82% |
| 3 | Technology | 0.59% |
| 4 | Financials | 0.04% |
| 5 | Consumer Discretionary | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Avantor
AVTR
$8.74B
| $21M | 0.21% |
512,216
| – | – |
|
102
American Well
AMWL
$112M
| $19.4M | 0.2% |
2,127,838
-13,920
| -0.6% | -$127K |
|
103
Transmedics
TMDX
$3.65B
| $19.2M | 0.2% |
581,029
-148,960
| -20% | -$4.93M |
|
|
ONEM
104
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $16.9M | 0.17% |
836,190
| – | – |
|
105
Legend Biotech
LEGN
$6.64B
| $14.5M | 0.15% |
286,556
-103,607
| -27% | -$5.24M |
|
106
Q32 Bio
QTTB
$20.9M
| $13.7M | 0.14% |
1,737,122
| – | – |
|
107
CVS Health
CVS
$93B
| $13.5M | 0.14% |
158,548
-1,600
| -1% | -$136K |
|
108
Zai Lab
ZLAB
$3.48B
| $13.2M | 0.13% |
125,000
+3,000
| +2% | +$316K |
|
109
Wave Life Sciences
WVE
$1.27B
| $12.8M | 0.13% |
2,602,858
| – | – |
|
110
Labcorp
LH
$22.8B
| $12.4M | 0.13% |
44,100
+7,900
| +22% | +$2.22M |
|
111
Privia Health
PRVA
$2.84B
| $12.4M | 0.13% |
525,000
| – | – |
|
112
NeueHealth
NEUE
$60.6M
| $12.2M | 0.12% |
1,500,000
| – | – |
|
113
Oscar Health
OSCR
$4.57B
| $11.8M | 0.12% |
679,952
-14,184
| -2% | -$247K |
|
|
IMAB
114
I-MAB
IMAB
$380M
| $11.8M | 0.12% |
162,957
-20,500
| -11% | -$1.49M |
|
115
Gilead Sciences
GILD
$140B
| $11M | 0.11% |
157,000
+46,000
| +41% | +$3.21M |
|
116
Inogen
INGN
$213M
| $10.4M | 0.11% |
242,174
-38,689
| -14% | -$1.67M |
|
|
GTH
117
DELISTED
Genetron Holdings Limited ADS
GTH
| $10M | 0.1% |
723,137
| – | – |
|
118
Dentsply Sirona
XRAY
$2.77B
| $9.24M | 0.09% |
159,129
| – | – |
|
|
SGEN
119
DELISTED
Seagen Inc. Common Stock
SGEN
| $9.07M | 0.09% |
53,400
+25,900
| +94% | +$4.4M |
|
|
BNR
120
Burning Rock Biotech
BNR
$85.6M
| $8.76M | 0.09% |
489,890
| – | – |
|
|
ONC
121
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $8.35M | 0.08% |
23,000
-61,300
| -73% | -$22.3M |
|
122
Neuropace
NPCE
$310M
| $8.05M | 0.08% |
507,930
| – | – |
|
|
CELL
123
DELISTED
PhenomeX Inc. Common Stock
CELL
| $7.53M | 0.08% |
385,014
| – | – |
|
124
Amgen
AMGN
$153B
| $7.22M | 0.07% |
33,950
-95,630
| -74% | -$20.3M |
|
125
Glaukos
GKOS
$5.42B
| $6.93M | 0.07% |
143,870
-351,562
| -71% | -$16.9M |
|